{ "access": { "embargo": { "active": false, "reason": null }, "files": "public", "record": "public", "status": "open" }, "created": "2020-09-20T10:25:55.995266+00:00", "custom_fields": {}, "deletion_status": { "is_deleted": false, "status": "P" }, "files": { "count": 1, "enabled": true, "entries": { "Ivermectin-19.pdf": { "checksum": "md5:e22fac284dc689f2ca3b4461dc77b679", "ext": "pdf", "id": "4c2164bc-85db-4dae-8158-79f366967d1a", "key": "Ivermectin-19.pdf", "metadata": null, "mimetype": "application/pdf", "size": 567840 } }, "order": [], "total_bytes": 567840 }, "id": "4039440", "is_draft": false, "is_published": true, "links": { "access": "https://zenodo.org/api/records/4039440/access", "access_links": "https://zenodo.org/api/records/4039440/access/links", "access_request": "https://zenodo.org/api/records/4039440/access/request", "access_users": "https://zenodo.org/api/records/4039440/access/users", "archive": "https://zenodo.org/api/records/4039440/files-archive", "archive_media": "https://zenodo.org/api/records/4039440/media-files-archive", "communities": "https://zenodo.org/api/records/4039440/communities", "communities-suggestions": "https://zenodo.org/api/records/4039440/communities-suggestions", "doi": "https://doi.org/10.5281/zenodo.4039440", "draft": "https://zenodo.org/api/records/4039440/draft", "files": "https://zenodo.org/api/records/4039440/files", "latest": "https://zenodo.org/api/records/4039440/versions/latest", "latest_html": "https://zenodo.org/records/4039440/latest", "media_files": "https://zenodo.org/api/records/4039440/media-files", "parent": "https://zenodo.org/api/records/3893750", "parent_doi": "https://zenodo.org/doi/10.5281/zenodo.3893750", "parent_html": "https://zenodo.org/records/3893750", "requests": "https://zenodo.org/api/records/4039440/requests", "reserve_doi": "https://zenodo.org/api/records/4039440/draft/pids/doi", "self": "https://zenodo.org/api/records/4039440", "self_doi": "https://zenodo.org/doi/10.5281/zenodo.4039440", "self_html": "https://zenodo.org/records/4039440", "self_iiif_manifest": "https://zenodo.org/api/iiif/record:4039440/manifest", "self_iiif_sequence": "https://zenodo.org/api/iiif/record:4039440/sequence/default", "versions": "https://zenodo.org/api/records/4039440/versions" }, "media_files": { "count": 0, "enabled": false, "entries": {}, "order": [], "total_bytes": 0 }, "metadata": { "additional_descriptions": [ { "description": "Before reading this work, please consider that I am not a physician. I do not suggest the use of ivermectin. I am not touting this drug. This analysis of publications and news about ivermectin is made in the framework of a wider investigation about information concerning drugs used for Covid-19.", "type": { "id": "notes", "title": { "de": "Anmerkungen", "en": "Notes" } } } ], "creators": [ { "affiliations": [ { "name": "Politecnico di Torino" } ], "person_or_org": { "family_name": "Sparavigna", "given_name": "Amelia Carolina", "identifiers": [ { "identifier": "0000-0003-4502-8974", "scheme": "orcid" } ], "name": "Sparavigna, Amelia Carolina", "type": "personal" } } ], "description": "
Discussion of scholarly papers published on Ivermectin, starting from the article of Caly et al. in Antiviral Research, available online April 3, 2020, and of some news that we can find about the use of this drug for the treatment of Covid-19. A list of clinical trials is also given. The proposed discussion was made in a series of versions from 14 June to 29 July 2020. Here updates (September 8, September 20). For what concerns scholarly papers, we report among them three preprints in MedRχiv. One, posted on 10 June, concludes that Ivermectin was associated with lower mortality during treatment of Covid-19. The other preprints, posted on 8 July and 15 September, are showing results of clinical studies. The preprint of July 8 tells, in its conclusions that add-on use of Ivermectin is giving better results when compared to controls, in particular a significant shorter hospitalization. The preprint of September 15 is reporting about the use of ivermectin, dexamethasone, enoxaparin and aspirin in the treatment of Covid-19. A preprint, posted in Research Square on July 14, is reported too. This preprint is giving the result of a trial regarding the combinations Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin. Among news, we consider especially the news regarding the use of Ivermectin in Peru. The case of Iquitos is discussed in detail. Epidemic data in this region are considered. News displaying the observation of rare symptoms of Covid-19, is also reported in detail. The observation was related to a large set of patients in Lima. The updates (8 September 2020 and 20 September 2020) are given in Appendix B and C.
", "languages": [ { "id": "eng", "title": { "en": "English" } } ], "publication_date": "2020-09-20", "publisher": "Zenodo", "resource_type": { "id": "publication-workingpaper", "title": { "de": "Arbeitspapier", "en": "Working paper" } }, "rights": [ { "description": { "en": "The Creative Commons Attribution license allows re-distribution and re-use of a licensed work on the condition that the creator is appropriately credited." }, "icon": "cc-by-icon", "id": "cc-by-4.0", "props": { "scheme": "spdx", "url": "https://creativecommons.org/licenses/by/4.0/legalcode" }, "title": { "en": "Creative Commons Attribution 4.0 International" } } ], "subjects": [ { "subject": "Covid-19" }, { "subject": "Ivermectin" }, { "subject": "Hydroxychloroquine" }, { "subject": "Doxycycline" }, { "subject": "azithromycin" }, { "subject": "Covid-19 rare symptoms" } ], "title": "Ivermectin for Covid-19" }, "parent": { "access": { "owned_by": { "user": 41891 } }, "communities": { "default": "10f33f78-3f29-41b6-bb10-f757a8f03cb8", "entries": [ { "access": { "member_policy": "open", "members_visibility": "public", "record_policy": "open", "review_policy": "open", "visibility": "public" }, "children": { "allow": false }, "created": "2020-03-16T11:40:44.487619+00:00", "custom_fields": {}, "deletion_status": { "is_deleted": false, "status": "P" }, "id": "10f33f78-3f29-41b6-bb10-f757a8f03cb8", "links": {}, "metadata": { "curation_policy": "The Coronavirus Disease Research Community - COVID-19 is curated by a selected team of experts nominated by OpenAIRE* (see list below). Each time a Zenodo user wants to add a record into the community, an email is sent to the curators that will decide whether to include the record or not.
\r\n\r\nOnly records that may be relevant to the Corona Virus Disease (COVID-19) or the SARS-CoV-2 should be included in this community. The Community curators are not able to edit records, therefore they may ask the corresponding authors to modify the record metadata when necessary, to provide the readers/users with more detailed information according to the FAIR principle of Open Science.
\r\n\r\nIf after its acceptance, a record is subsequently found not to be compliant, we reserve the right to remove it from the community.
\r\n\r\nThe curation team is reachable through the following email address for further clarification or information: covid19@openaire.eu.
\r\n\r\nCurator List:
\r\n\r\n* OpenAIRE: open access and open science training and support since 2009. OpenAIRE is the largest aggregator of European Commission funded research outputs and beyond, also delivering on-demand services for research communities.
\r\n", "page": "This community collects research outputs that may be relevant to the Coronavirus Disease (COVID-19) or the SARS-CoV-2. Scientists are encouraged to upload their outcome in this collection to facilitate sharing and discovery of information. Although Open Access articles and datasets are recommended, also closed and restricted access material are accepted. All types of research outputs can be included in this Community (Publication, Poster, Presentation, Dataset, Image, Video/Audio, Software, Lesson, Other).
\r\n\r\nThe recent Corona Virus Disease (COVID-19) outbreak is requiring unseen efforts of collaboration of the scientific community that need to act fast and to share results in an unpredictable manner. In order to facilitate the Scientist efforts, this community was created to collect all research results that could be relevant for the scientific community working on the Corona Virus Disease (COVID-19) and SARS-CoV-2.
\r\n\r\nAlthough Open Access articles and datasets are recommended, also closed and restricted access material are accepted. All types of research outputs can be included in this Community (Publication, Poster, Presentation, Dataset, Image, Video/Audio, Software, Lesson, Other).
\r\n\r\nWhen depositing a resource that is linked to other resources (not limited to the records deposited in Zenodo but also in other repositories), please make sure that your record is linked to all the other related elements already available, in order to adhere to the FAIR principles of Open Science to maximise the reusability of research results.
\r\n\r\n", "title": "Coronavirus Disease Research Community - COVID-19" }, "revision_id": 0, "slug": "covid-19", "updated": "2021-02-23T14:39:53.029415+00:00" } ], "ids": [ "10f33f78-3f29-41b6-bb10-f757a8f03cb8" ] }, "id": "3893750", "pids": { "doi": { "client": "datacite", "identifier": "10.5281/zenodo.3893750", "provider": "datacite" } } }, "pids": { "doi": { "client": "datacite", "identifier": "10.5281/zenodo.4039440", "provider": "datacite" }, "oai": { "identifier": "oai:zenodo.org:4039440", "provider": "oai" } }, "revision_id": 3, "stats": { "all_versions": { "data_volume": 1809080925.0, "downloads": 4470, "unique_downloads": 4101, "unique_views": 8075, "views": 9910 }, "this_version": { "data_volume": 722860320.0, "downloads": 1273, "unique_downloads": 1174, "unique_views": 1824, "views": 1954 } }, "status": "published", "updated": "2020-09-22T00:26:53.033484+00:00", "versions": { "index": 19, "is_latest": true } }